Novo Nordisk A/S (NOVC.DE) XETRA

91.40

-1.85(-1.98%)

Updated at November 14, 2023 04:35PM

Currency In EUR

Valuation

Market Cap3.06T
Enterprise Value3.07T
P/E Ratio13.27
PEG Ratio2.14
Price/Sales Ratio4.72
Price/Book Ratio8.77
Enterprise/Revenue4.98
Enterprise/EBITDA10.07

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0.36
Operating Margin0.46

Management Effectiveness

Return On Assets0.23
Return On Equity0.78

Income Statement

Revenue232.26B
Revenue/Share70.15
Gross Profit196.5B
EBITDA114.63B
Net Income83.68B
Diluted EPS18.62

Balance Sheet

Total Cash74.88B
Total Cash/Share4.26
Total Debt56.97B
Total Debt/Equity0.59
Current Ratio0.78
Book Value Per Share37.79

Price History

52-Week Change69.64
52-Week High185.12
52-Week Low51.65
Moving Average 50 Days85.46
Moving Average 200 Days74.38

Statistics

Average Volume51,037
Shares Outstanding4.45B
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate11.65
Trailing Annual Dividend Yield3.51
Payout Ratio0.46
Last Split Factor2:1
Last Split DateSeptember 13, 2023